Early statin use is associated with increased risk of infection after stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 1, 2013, Pages 66-71

  Becker, Kyra ^a   Tanzi, Pat ^a   Kalil, Angela ^a   Shibata, Dean ^b   Cain, Kevin ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

infection; Interleukin 1 receptor antagonist; statins; stroke

Indexed keywords

ATORVASTATIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; COMMUNICABLE DISEASES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; TIME FACTORS; UP-REGULATION;

EID: 84871281095     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2011.06.008     Document Type: Article

References (32)

1. S. Aslanyan, C.J. Weir, and H.C. Diener Pneumonia and urinary tract infection after acute ischaemic stroke: A tertiary analysis of the gain international trial Eur J Neurol 11 2004 49 53 (Pubitemid 38174922)
2. K.S. Hong, D.W. Kang, and J.S. Koo Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke Eur J Neurol 15 2008 1324 1331
3. F.H. Vermeij, W.J. Scholte op Reimer, and P. de Man Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: Data from the Netherlands stroke survey Cerebrovasc Dis 27 2009 465 471
4. B. Indredavik, G. Rohweder, and E. Naalsund Medical complications in a comprehensive stroke unit and an early supported discharge service Stroke 39 2008 414 420 (Pubitemid 351619465)
5. U. Walter, R. Knoblich, and V. Steinhagen Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit J Neurol 254 2007 1323 1329 (Pubitemid 350112314)
6. P. Tanzi, K. Cain, and A. Kalil Post-stroke infection: A role for il-1ra? Neurocrit Care 14 2011 244 252
7. K. Prass, C. Meisel, and C. Hoflich Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation J Exp Med 198 2003 725 736 (Pubitemid 37087772)
8. A. Hug, A. Dalpke, and N. Wieczorek Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection Stroke 40 2009 3226 3232
9. K.G. Haeusler, W.U. Schmidt, and F. Fohring Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans Cerebrovasc Dis 25 2008 50 58 (Pubitemid 351280375)
10. H.P. Adams Jr., G. del Zoppo, and M.J. Alberts Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Stroke 38 2007 1655 1711 (Pubitemid 46691097)
11. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial Lancet 360 2002 7 22
12. P. Amarenco, L.B. Goldstein, and M. Szarek Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial Stroke 38 2007 3198 3204 (Pubitemid 350175737)
13. B. Ovbiagele, L.H. Schwamm, and E.E. Smith Recent nationwide trends in discharge statin treatment of hospitalized patients with stroke Stroke 41 2010 1508 1513
14. J. Marti-Fabregas, M. Gomis, and A. Arboix Favorable outcome of ischemic stroke in patients pretreated with statins Stroke 35 2004 1117 1121 (Pubitemid 38543528)
15. J.R. Sims, L.R. Gharai, and P.W. Schaefer ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes Neurology 72 2009 2104 2110
16. J. Greenwood, L. Steinman, and S.S. Zamvil Statin therapy and autoimmune disease: From protein prenylation to immunomodulation Nat Rev Immunol 6 2006 358 370
17. J. Montaner, P. Chacon, and J. Krupinski Simvastatin in the acute phase of ischemic stroke: A safety and efficacy pilot trial Eur J Neurol 15 2008 82 90 (Pubitemid 350265291)
18. + monocytes Arterioscler Thromb Vasc Biol 25 2005 1439 1445 (Pubitemid 40923365)
19. H. Bessler, H. Salman, and M. Bergman In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells Clin Immunol 117 2005 73 77 (Pubitemid 41725472)
20. E. Ascer, M.C. Bertolami, and M.L. Venturinelli Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients Atherosclerosis 177 2004 161 166 (Pubitemid 39361151)
21. D. Ferro, S. Parrotto, and S. Basili Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia J Am Coll Cardiol 36 2000 427 431 (Pubitemid 30624003)
22. T. Kishimoto IL-6: From its discovery to clinical applications Int Immunol 22 2010 347 352
23. A. Chamorro, S. Amaro, and M. Vargas Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke J Neurol Neurosurg Psychiatry 77 2006 1279 1281 (Pubitemid 44654763)
24. N. de Bont, M.G. Netea, and C. Rovers LPS-induced release of IL-1 beta, IL-1ra, IL-6, and TNF-alpha in whole blood from patients with familial hypercholesterolemia: No effect of cholesterol-lowering treatment J Interferon Cytokine Res 26 2006 101 107 (Pubitemid 43364047)
25. B. Fuentes, P. Martinez-Sanchez, and E. Diez-Tejedor Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome Cerebrovasc Dis 27 Suppl 1 2009 126 133
26. L.X. Cubeddu, and M.J. Seamon Statin withdrawal: Clinical implications and molecular mechanisms Pharmacotherapy 26 2006 1288 1296 (Pubitemid 44306889)
27. M. Endres, and U. Laufs Discontinuation of statin treatment in stroke patients Stroke 37 2006 2640 2643 (Pubitemid 44454692)
28. M. Blanco, F. Nombela, and M. Castellanos Statin treatment withdrawal in ischemic stroke: A controlled randomized study Neurology 69 2007 904 910 (Pubitemid 47329591)
29. S. Janda, A. Young, and J.M. Fitzgerald The effect of statins on mortality from severe infections and sepsis: A systematic review and meta-analysis J Crit Care 25 2010 656.e7 656.e22
30. P.S. Kruger, M.L. Harward, and M.A. Jones Continuation of statin therapy in patients with presumed infection: A randomized controlled trial Am J Respir Crit Care Med 183 2011 774 781
31. R. Collins, J. Armitage, and S. Parish Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions Lancet 363 2004 757 767
32. P. Amarenco, J. Bogousslavsky, and A. Callahan 3rd High-dose atorvastatin after stroke or transient ischemic attack N Engl J Med 355 2006 549 559 (Pubitemid 44202151)